Utility of Endoscopic Ultrasound-Guided Tissue Acquisition for Precision Medicine -Multicenter Prospective Cohort Study-

Utility of Endoscopic Ultrasound-Guided Tissue Acquisition for Precision Medicine -Multicenter Prospective Cohort Study- - EUS-TA for Precision Medicine of PDAC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047173

Enrollment

Registered

2022-03-15

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 20 years old and over 2. Cases that have been pathologically diagnosed as unresectable pancreatic malignant tumor 3. Cases scheduled to undergo cancer genome testing using EUS-FNA specimens 4. Patients who have received sufficient explanation about participation in the study, and after sufficient understanding, have obtained written consent by the patient's free will.

Exclusion criteria

Exclusion criteria: 1. Cases who are thought to be ineligible for this study

Design outcomes

Primary

Measure	Time frame
Success rate of multi gene panel using EUS-FNA specimens	—

Secondary

Measure	Time frame
Patient background factors and procedure factors involved in the success of multi gene panel using EUS-FNA specimens	—

Countries

Japan

Contacts

Public ContactREIKO ASHIDA

Wakayama Medical University Second Department of Internal Medicine

ninai@wakayama-med.ac.jp073-447-2300

Outcome results